Physician profile
Kathryn G Luse
NPI 1588890834
$4,265.31
in general payments reported to CMS, 2019-2025
9 companies · $245 in 2025
The $245 reported for 2025 was more than what 80% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $150 · 2021: $3,334 · 2022: $104 · 2023: $280 · 2024: $20.43 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $314 · Food and Beverage: $201 · Consulting Fee: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $314.13 |
| Food and Beverage | $201.35 |
| Consulting Fee | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,713.75 | 2021 | |
| Straumann USA LLC | $1,161.96 | 2019-2025 | |
| Align Technology, INC. | $222.15 | 2019-2025 | Invisalign, Itero Element 5d Plus, Invisalign System - Moderate |
| Philips North America LLC | $63.62 | 2019-2024 | (E55) Oral Health Care Und |
| 3m Company | $45.58 | 2021 | |
| Dentsply Sirona INC | $15.22 | 2023 | Suresmile |
| Elevate Oral Care | $14.48 | 2023 | Fluorimax Mint, Fluorimax 5000, Just Right 5000 |
| Ultradent Products INC | $14.42 | 2022 | |
| Gc America INC. | $14.13 | 2023 | Equia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Luse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.